Product Information

AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3362 per EA under NDC 33342019107. Its NADAC has been published 513 times since Jan 18, 2017.

FDA first approved this application on Oct 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 5-40 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.3362per EA

Strength

5; 40 mg/1; mg/1

NDC

33342019107

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

FDA Approved

10/26/2016

TE Code

AB

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 513 times since Jan 18, 2017, and over the history we have for it it has declined 67.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3362 per EA
All-time high$1.1864 (Apr 12, 2017)
All-time low$0.2762 (Apr 22, 2026)
52-week high$0.3362
52-week low$0.2762
Median price$0.4599
Average price$0.5588
Largest weekly change-45.3% (Nov 18, 2020)
Weeks tracked513
Tracking sinceJan 18, 2017

Price History

1W

0.0%

1M

+5.5%

3M

+11.0%

6M

+21.7%

1Y

-5.6%

3Y

-9.2%

5Y

-8.7%

All

-67.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.3362 per EA (NDC 33342019107), effective Nov 11, 2026.

How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has declined 67.6%. It has been tracked across 513 weekly CMS publications since Jan 18, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?

Since Jan 18, 2017, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $1.1864 (Apr 12, 2017), with a median of $0.4599 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-40 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?

AMLODIPINE-OLMESARTAN 5-40 MG (NDC 33342019107) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.